Variant report
Variant | nsv528514 |
---|---|
Chromosome Location | chr17:44979705-44983181 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:44982902..44984528-chr17:44989442..44992407,2 | K562 | blood: | |
2 | chr17:44974235..44975776-chr17:44981601..44983769,2 | K562 | blood: | |
3 | chr17:44980885..44982859-chr17:44998569..45001010,2 | MCF-7 | breast: | |
4 | chr17:44976318..44978011-chr17:44981364..44983964,2 | K562 | blood: | |
5 | chr17:44982234..44984014-chr17:45005166..45007066,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000262633 | chromatin interactions |
ENSG00000108433 | chromatin interactions |
ENSG00000261886 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs197943 | chr17:44979705-44979706 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs79507995 | chr17:44979717-44979718 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs145135563 | chr17:44979740-44979741 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs548251631 | chr17:44979812-44979813 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs58371473 | chr17:44979827-44979828 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs372785708 | chr17:44979828-44979829 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs3039756 | chr17:44979834-44979835 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs34649681 | chr17:44979848-44979849 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs5820634 | chr17:44979855-44979856 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs568062104 | chr17:44979870-44979871 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536999877 | chr17:44979928-44979929 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs7210725 | chr17:44979932-44979933 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs531889181 | chr17:44979969-44979970 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs544230109 | chr17:44979970-44979971 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs576833710 | chr17:44979996-44979997 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs539644630 | chr17:44980001-44980002 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs562434944 | chr17:44980059-44980060 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs533083156 | chr17:44980117-44980118 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs139040009 | chr17:44980170-44980171 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs573131846 | chr17:44980248-44980249 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs186688374 | chr17:44980282-44980283 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs192457113 | chr17:44980299-44980300 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs551451068 | chr17:44980306-44980307 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs575243137 | chr17:44980346-44980347 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs544166609 | chr17:44980410-44980411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs142136405 | chr17:44980423-44980424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533246469 | chr17:44980485-44980486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs185884027 | chr17:44980509-44980510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs560513022 | chr17:44980562-44980563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs188301524 | chr17:44980571-44980572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs549703294 | chr17:44980583-44980584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs563940814 | chr17:44980585-44980586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs547356674 | chr17:44980640-44980641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs537063593 | chr17:44980641-44980642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs541018657 | chr17:44980648-44980649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs548479421 | chr17:44980649-44980650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs35009957 | chr17:44980660-44980661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs193190499 | chr17:44980674-44980675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs78897414 | chr17:44980760-44980761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs539148721 | chr17:44980835-44980836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs553179715 | chr17:44980863-44980864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs201016725 | chr17:44980870-44980871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs535231881 | chr17:44980915-44980916 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
44 | rs77475166 | chr17:44980917-44980918 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
45 | rs575169628 | chr17:44980930-44980931 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
46 | rs544227261 | chr17:44980976-44980977 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
47 | rs540173354 | chr17:44980993-44980994 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
48 | rs567582863 | chr17:44981025-44981026 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
49 | rs197944 | chr17:44981046-44981047 | Weak transcription | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs556158558 | chr17:44981051-44981052 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Melanoma | 18172304 | CNVD |
Moyamoya disease | 22323933 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Cancer | 16751803 | CNVD |
Chordoma | 21602918 | CNVD |
Neurofibromatosis | 20686819 | CNVD |
Peripheral nerve sheath tumors | 20686819 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Breast cancer | 21264507 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Gastric cancer | 17167181 | CNVD |
Breast cancer | 19287154 | CNVD |
Leukemia | 20874852 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 17457667 | CNVD |
Breast cancer | 16951389 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 22048815 | CNVD |
Breast cancer | 17603634 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 20953835 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
TAR Syndrome | 17847015 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 19261255 | CNVD |
Lung cancer | 16773561 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Basal-like breast cancer | 18066063 | CNVD |
Breast cancer | 20031965 | CNVD |
Colorectal cancer | 19287155 | CNVD |
Hereditary breast | 19566914 | CNVD |
Ovarian cancer | 19047089 | CNVD |
Ovarian cancer | 19566914 | CNVD |
Triple-negative breast cancer | 18950515 | CNVD |
Breast cancer | 16846527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21509527 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Breast cancer | 17142309 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 16397240 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 17217626 | CNVD |
Non-syndromic sensorineural hearing loss | 21084979 | CNVD |
Autism | 22817714 | CNVD |
Breast cancer | 20409316 | CNVD |
Cancer | 17160897 | CNVD |
Frontotemporal lobar degeneration | 19640594 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:44973000-44987200 | Weak transcription | Pancreas | Pancrea |
2 | chr17:44979600-44979800 | Enhancers | K562 | blood |
3 | chr17:44979600-44980000 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
4 | chr17:44979600-44980200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr17:44979600-44980400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr17:44980000-44982800 | Weak transcription | K562 | blood |
7 | chr17:44980000-44983000 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
8 | chr17:44980200-44983000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
9 | chr17:44980400-44982800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
10 | chr17:44982800-44983200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr17:44982800-44983200 | Bivalent Enhancer | HepG2 | liver |
12 | chr17:44982800-44983200 | Enhancers | K562 | blood |
13 | chr17:44982800-44983400 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
14 | chr17:44982800-44983600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr17:44982800-44983800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
16 | chr17:44982800-44983800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
17 | chr17:44982800-44984200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
18 | chr17:44982800-44984200 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
19 | chr17:44982800-44985800 | Enhancers | Spleen | Spleen |
20 | chr17:44983000-44983600 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
21 | chr17:44983000-44983600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
22 | chr17:44983000-44983600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
23 | chr17:44983000-44983600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
24 | chr17:44983000-44983600 | Enhancers | Primary hematopoietic stem cells | blood |
25 | chr17:44983000-44983800 | Enhancers | Primary monocytes fromperipheralblood | blood |
26 | chr17:44983000-44984200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
27 | chr17:44983000-44984800 | Enhancers | Lung | lung |